Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
08/2007
08/16/2007WO2007090840A1 4-phenyl-3-(2-propylsulfonylamino) tetrahydrofuran derivatives which potentiate glutamate receptors and are useful in the treatment of schizophrenia
08/16/2007WO2007090494A1 Amino indazole derivatives
08/16/2007WO2007090493A1 Indazole heteroaryl derivatives
08/16/2007WO2007070826B1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
08/16/2007US20070191466 Metabolites of wortmannin analogs and methods of using the same
08/16/2007US20070191456 Novel process for the preparation of 1-(9h-carbazol-4-yloxy)-3-[[2-(-methoxyphenoxy)-ethyl] amino]-propan-2-ol
08/16/2007US20070191431 2-Amino-5-piperidinylimidazolone compounds and use thereof for beta-secretase modulation
08/16/2007US20070191429 Ppar activators
08/16/2007US20070191426 Derivatives of 3-aminocarbonylquinoline, pharmaceutical compositions containing them and processes and intermediates for their preparation
08/16/2007US20070191420 Kinase inhibitors
08/16/2007US20070191403 e.g. 3-[{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methylpyrimidine-2,4(1H,3H)-dione; sex-hormone related diseases; anticarcinogenic agent; endometriosis, uterine fibroids, polycystic ovarian disease
08/16/2007US20070191364 Aminopiperidine derivatives, preparation thereof and therapeutic use thereof
08/16/2007US20070191347 Substituted sulfonamides and ureas useful for inhibiting kinase activity
08/16/2007US20070191346 3-Cyano-quinoline derivatives
08/16/2007US20070191345 3-((Hetero)arylsulfonyl)-8-'(aminoalkyl)oxyquinolines as 5-ht6 receptor antagonists for the treatment of cns disorders
08/16/2007US20070191344 Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
08/16/2007US20070191341 N-Substituted Benzene Sulfonamides
08/16/2007US20070189967 a mixture of a benzofuran derivatives such as [2-(2-formyl-5-furanyl)-3-hydroxymethyl benzofuran], and a label selected from radioisotopes, paramagnetic particles and optical particles, used for in vivo and in vitro detection beta-amyloid in a sample of brain tissues; noninvasive medical diagnosis
08/16/2007US20070189865 Amino cyclopropane carboxamide derivatives as bradykinin antagonists
08/16/2007DE19823102B4 Flüssige Antioxidantien als Stabilisatoren Liquid antioxidants as stabilizers
08/16/2007CA2651987A1 Piperidinyl derivatives as modulators of chemokine receptor activity
08/16/2007CA2641591A1 Multinuclear complex and polymer thereof
08/16/2007CA2641350A1 Aminoindazole derivatives
08/16/2007CA2641347A1 Indazole-heteroaryl derivatives
08/16/2007CA2640652A1 Novel coumarin derivative having antitumor activity
08/16/2007CA2637768A1 Benzamide and heteroarene derivatives
08/16/2007CA2635138A1 Piperidine derivatives as cxcr3 receptor antagonists
08/15/2007EP1818332A1 Process for producing epoxytriazole derivative
08/15/2007EP1818326A1 Nitrogen-containing heterocyclic compounds and pharmaceutical composition containing the compounds
08/15/2007EP1818325A2 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
08/15/2007EP1817834A1 Method and installation means for installing an electrical machine
08/15/2007EP1817308A2 Cyclopamine analogues and methods of use thereof
08/15/2007EP1817306A1 Triazoles and their use as bradykinin b1 receptor antagonists
08/15/2007EP1817295A1 Triazole compounds that modulate hsp90 activity
08/15/2007EP1817294A1 1,2,3,4-tetrahydropyrazin-2-yl acetamides and their use as bradykinin antagonists for the treatment of inflammation related disorders
08/15/2007EP1817292A2 Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms)
08/15/2007EP1817285A2 Cycloalkyl keto piperidine tachykinin receptor antagonists
08/15/2007EP1817281A1 N- [(3s)- pyrrolidin-3-yl]- benzamide derivatives as monoamine re-uptake inhibitors
08/15/2007EP1817030A2 Inducible nitric oxide synthase dimerization inhibitors
08/15/2007EP1467974B1 Benzimidazole derivatives and their use as gnrh antagonists
08/15/2007EP1435947B1 2-phenyl benzimidazoles and imidazo-¬4,5|-pyridines as cds1/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer
08/15/2007CN1331862C Di-aryl acid derivatives as PPAR receptor ligands
08/15/2007CN1331853C Small molecule inhibitors of rotamase enzyme activity
08/15/2007CN1331848C Tricyclic steroid hormone nuclear receptor modulators
08/15/2007CN101018783A Quinoxaline inhibitors of the HEDGEHOG signalling pathway
08/15/2007CN101018552A Intracellular receptor modulator compounds and methods
08/15/2007CN101016296A Muscarinic agonists
08/15/2007CN101016294A Substituted indole-3-oxalamide derivative with multiple bioactivity
08/14/2007US7257287 Optical interleaver
08/14/2007US7256289 Serotonin receptor antagonists; nervous system disorders, R)-4-(2,3-dihydro-1,4-benzodioxin-5-yl)- beta -methyl-1-piperazineethanol
08/14/2007US7256213 Taxanes having a C10 carbonate substituent
08/14/2007US7256212 Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
08/14/2007US7256203 Dicationic 2,5-diarylfuran aza-analogs as anti-protozoan agents
08/14/2007US7256201 Selective estrogen receptor-β ligands
08/14/2007US7256193 Therapeutic agents useful for treating pain
08/14/2007US7256190 Thiazole compounds useful as inhibitors of protein kinase
08/14/2007US7256158 Animal husbandry; veterinary medicine
08/09/2007WO2007090068A2 Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (hif)
08/09/2007WO2007089768A2 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them
08/09/2007WO2007089683A1 Amido compounds and their use as pharmaceuticals
08/09/2007WO2007089626A2 Anabaseine derivatives, pharmaceutical compositions and methods of use thereof
08/09/2007WO2007089018A1 Triazole derivative
08/09/2007WO2007088996A1 Trisubstituted amine compounds as inhibitors of -cholesteryl ester transfer protein cetp
08/09/2007WO2007088876A1 Pyridone derivative and herbicide
08/09/2007WO2007088181A1 Novel dual nk2/nk3-antagonists, pharmaceutical compositions comprising them and processes for their preparations
08/09/2007WO2007071963A3 Quinazoline derivatives, process for their preparation and their use as anti-cancer agents
08/09/2007WO2006119400A3 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-trianzin-6-ones, and their use as fungicides
08/09/2007US20070185326 Heterocyclic compound
08/09/2007US20070185283 Perdeuterated polyimide, their process of preparation and their use as materials which are transparent within the region from 2500 to 3500 cm-1
08/09/2007US20070185169 2-Mercapto-4,5-Diarylimidazole Derivatives and the use thereof as Cyclooxygenase Inhibitors
08/09/2007US20070185163 Imidazol derivatives of piperidine as histamine antagonists
08/09/2007US20070185161 N-[3-(1-Ethyl-5-fluoro-indan-1-yl)-1H-indol-7-yl]-methanesulfonamide; for treating congestive heart disease, hypertension, and atherosclerosis
08/09/2007US20070185107 Chroman compounds
08/09/2007US20070185091 Bicyclic Heterocycles, Pharmaceutical Compositions Containing These Compounds, Their Use and Processes for Preparing Them
08/09/2007US20070185089 Benzazepine derivatives for the treatment of neurological and psychiatric disorders
08/09/2007US20070185063 Seven-membered ring nucleosides
08/09/2007US20070184559 Method and compounds for the fluorescent labelling of biomolecules and polymer particles
08/09/2007US20070184304 Light-emitter with a light-emitting layer containing a 4-(dicyanomethylene)-2,6-bis(9-[1,1,7,7-tetramethyl-8-alkoxyjulolidyl])-4H-pyran; inferior luminescence properties due to carbonization during vapor deposition; optionally rubrene, 9,10-di(2-naphthyl)anthracene, or 8-hydroxyquinoline aluminum
08/09/2007DE102006005180A1 Indazol-heteroaryl-derivate Indazole-heteroaryl derivatives
08/09/2007DE102006005179A1 Aminoindazolderivate Aminoindazolderivate
08/09/2007CA2641817A1 Novel dual nk2/nk3-antagonists, pharmaceutical compositions comprising them and processes for their preparation
08/09/2007CA2640398A1 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them
08/09/2007CA2637545A1 Anabaseine derivatives, pharmaceutical compositions and methods of use thereof
08/09/2007CA2635814A1 Amido compounds and their use as pharmaceuticals
08/08/2007EP1816131A1 Process for the preparation of olmesartan medoxomil
08/08/2007EP1816130A1 Novel nucleoside or nucleotide derivative and use thereof
08/08/2007EP1815872A1 Composition for amyloid-associated disease diagnosis
08/08/2007EP1815860A2 Phosphate transport inhibitors
08/08/2007EP1814900A1 Agonists and antagonists of the somatostatin receptor
08/08/2007EP1814875A2 Improved inhibitors for the soluble epoxide hydrolase
08/08/2007EP1814869A2 Substituted amino acids as protein tyrosine phosphatase inhibitors
08/08/2007EP1814863A1 Indazole sulphonamide derivatives
08/08/2007EP1814859A2 Methods for preparing indazole compounds
08/08/2007EP1814856A1 Nitrogen heteroaromatic compounds which bind to the active site of protein kinase enzymes
08/08/2007EP1814849A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
08/08/2007EP1682499B1 4-biarylyl-1-phenylazetidin-2-ones
08/08/2007EP1631285B1 Therapeutic agents useful for treating pain
08/08/2007EP1611121B1 Pyridazinone derivatives as cdk2-inhibitors
08/08/2007EP1585742B1 Substituted benzoyl derivatives uses as herbicides
08/08/2007EP1554264B1 Medicinal arylethanolamine compounds